AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20054045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 917
Study 17914136 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0g instant black tea
Number of subjects: 16
Study 17914136 — intervention group
Group type: COMPARATOR
Intervention: 250ml of water (control)
Number of subjects: 16
Study 17914136 — intervention group
Group type: COMPARATOR
Intervention: 250ml of water plus 0.052g of caffeine (positive control)
Number of subjects: 16
Study 16056171 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 124
Study 16056171 — intervention group
Group type: COMPARATOR
Intervention: Nontailored intervention (Control)
Number of subjects: 124
Study 12269760 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational training program for hospital nurses on universal precautions
Number of subjects: 50
Study 12269760 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational training)
Number of subjects: 50
Study 10078398 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 52
Study 10078398 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 52
Study 8548111 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral antiarrhythmics
Number of subjects: 0
Study 1785181 — intervention group
Group type: EXPERIMENTAL
Intervention: Live recombinant influenza vaccine type A (H1N1)
Number of subjects: 0
Study 1785181 — intervention group
Group type: EXPERIMENTAL
Intervention: Live recombinant influenza vaccine type B
Number of subjects: 0
Study 1785181 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivaccine (combined A and B strains)
Number of subjects: 0
Study 1785181 — intervention group
Group type: COMPARATOR
Intervention: Mono-vaccine (either A or B)
Number of subjects: 0
Study 6269935 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate
Number of subjects: 3
Study 6269935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 31881987 — intervention group
Group type: EXPERIMENTAL
Intervention: app + tailored messages
Number of subjects: 42
Study 31881987 — intervention group
Group type: EXPERIMENTAL
Intervention: app + tailored messages + gamification I
Number of subjects: 42
Study 31881987 — intervention group
Group type: EXPERIMENTAL
Intervention: app + tailored messages + gamification II
Number of subjects: 42
Study 31881987 — intervention group
Group type: COMPARATOR
Intervention: physical activity counseling
Number of subjects: 42
Study 29789267 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery (occlusion at 171-266mmHg)
Number of subjects: 24
Study 29789267 — intervention group
Group type: COMPARATOR
Intervention: Control (occlusion at 15mmHg)
Number of subjects: 24
Study 26728364 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular Adsorbents Recirculating System (MARS)
Number of subjects: 32
Study 26728364 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Pass Albumin Dialysis (SPAD)
Number of subjects: 32
Study 24956325 — intervention group
Group type: EXPERIMENTAL
Intervention: SG-IVR (small group intervention plus 12 months of interactive voice response telephone follow-up)
Number of subjects: 600
Study 24956325 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD-IVR (DVD version of the small group intervention with the same IVR follow-up)
Number of subjects: 600
Study 24956325 — intervention group
Group type: EXPERIMENTAL
Intervention: SG (standard care, small group, diabetes prevention education class)
Number of subjects: 600
Study 22148919 — intervention group
Group type: EXPERIMENTAL
Intervention: Achilles tendon vibration (1 h daily at 50 Hz for 14 days)
Number of subjects: 29
Study 22148919 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vibration)
Number of subjects: 29
Study 20650600 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure (PE)
Number of subjects: 40
Study 20650600 — intervention group
Group type: COMPARATOR
Intervention: Supportive counseling (SC)
Number of subjects: 40
Study 17230607 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga sessions biweekly for 12 weeks
Number of subjects: 60
Study 17230607 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 60
Study 15109191 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation with midazolam (mean total dose 7.9 mg +/- 4.2 SD)
Number of subjects: 35
Study 15109191 — intervention group
Group type: COMPARATOR
Intervention: Operator-controlled sedation with midazolam (mean total dose 4.2 mg +/- 1.8 SD)
Number of subjects: 35
Study 11553900 — intervention group
Group type: EXPERIMENTAL
Intervention: 950 micros pulsed CO(2) laser (UPCO(2))
Number of subjects: 16
Study 11553900 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable pulsed erbium laser (VP Er:YAG)
Number of subjects: 16
Study 11553900 — intervention group
Group type: COMPARATOR
Intervention: Short pulse erbium laser
Number of subjects: 16
Study 9683314 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course (2 weeks) of systemic corticosteroids
Number of subjects: 1100
Study 9683314 — intervention group
Group type: EXPERIMENTAL
Intervention: Long course (8 weeks) of systemic corticosteroids
Number of subjects: 1100
Study 9683314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1100
Study 8147323 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol alone
Number of subjects: 16
Study 8147323 — intervention group
Group type: COMPARATOR
Intervention: Cigarettes alone
Number of subjects: 16
Study 8147323 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol plus cigarettes
Number of subjects: 16
Study 8147323 — intervention group
Group type: COMPARATOR
Intervention: Cigarettes with an energetic control
Number of subjects: 16
Study 3364519 — intervention group
Group type: EXPERIMENTAL
Intervention: Base-in prism (8 delta, 12 delta)
Number of subjects: 10
Study 3364519 — intervention group
Group type: EXPERIMENTAL
Intervention: Base-out prism (8 delta, 12 delta)
Number of subjects: 10
Study 3364519 — intervention group
Group type: EXPERIMENTAL
Intervention: Base-in prism (4 delta)
Number of subjects: 10
Study 3364519 — intervention group
Group type: EXPERIMENTAL
Intervention: Base-out prism (4 delta)
Number of subjects: 10
Study 3364519 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism glasses (3.0 to 6.7% performance decrement)
Number of subjects: 10
Study 3364519 — intervention group
Group type: COMPARATOR
Intervention: Denial of binocularity
Number of subjects: 10
Study 3364519 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading and counting tasks
Number of subjects: 10
Study 29112591 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol
Number of subjects: 12
Study 29112591 — intervention group
Group type: COMPARATOR
Intervention: Esmolol
Number of subjects: 12
Study 28263256 — intervention group
Group type: EXPERIMENTAL
Intervention: Average daily step count
Number of subjects: 128
Study 28263256 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cardiorespiratory fitness
Number of subjects: 128
Study 28263256 — intervention group
Group type: EXPERIMENTAL
Intervention: No fear/worry of falling
Number of subjects: 128
Study 28263256 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower motor severity examination score
Number of subjects: 128
Study 28263256 — intervention group
Group type: EXPERIMENTAL
Intervention: More recent time since Parkinson disease diagnosis
Number of subjects: 128
Study 28263256 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a cardiovascular condition
Number of subjects: 128
Study 27004324 — intervention group
Group type: EXPERIMENTAL
Intervention: Open haemorrhoidectomy (Milligan-Morgan technique)
Number of subjects: 364
Study 27004324 — intervention group
Group type: COMPARATOR
Intervention: Closed haemorrhoidectomy (Ferguson technique)
Number of subjects: 364
Study 23595762 — intervention group
Group type: COMPARATOR
Intervention: 5 Hz rTMS to the right dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 39
Study 21494892 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol IR 50 mg
Number of subjects: 0
Study 21494892 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol IR 75 mg
Number of subjects: 0
Study 21494892 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone HCl IR 10 mg
Number of subjects: 0
Study 21494892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18276017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 180
Study 18276017 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (PT)
Number of subjects: 180
Study 15145466 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter fluency task ("KA", "TA" in "kana" script)
Number of subjects: 38
Study 15145466 — intervention group
Group type: EXPERIMENTAL
Intervention: Category fluency task (ANIMAL, FRUIT)
Number of subjects: 38
Study 15145466 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogia symptoms (assessed by SANS)
Number of subjects: 38
Study 15145466 — intervention group
Group type: EXPERIMENTAL
Intervention: Other domains of negative symptoms (assessed by SANS)
Number of subjects: 38
Study 9925127 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplementation (8 mg elemental Fe, 5 mg elemental Zn, 333 microg retinol, 20 mg vitamin C 5 d/wk for 3 mo)
Number of subjects: 163
Study 9925127 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly supplementation (20 mg Fe, 17 mg Zn, 1700 microg retinol, 20 mg vitamin C once a week for 3 mo)
Number of subjects: 163
Study 9925127 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 7482713 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (FK506)
Number of subjects: 322
Study 7482713 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 322
Study 2181223 — intervention group
Group type: EXPERIMENTAL
Intervention: ICRC anti-leprosy vaccine
Number of subjects: 0
Study 2181223 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Education (person-to-person approach)
Number of subjects: 0
Study 2181223 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive programmes backed by curative services
Number of subjects: 0
Study 376132 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (procarbazine 100 mg/m2, Days 1‐‐10; vinblastine 5 mg/m2, Days 1 and 8; actinomycin D 0.5 mg/m2, Days 1 and 8)
Number of subjects: 79
Study 376132 — intervention group
Group type: COMPARATOR
Intervention: Combination chemotherapy with MER (200 micrograms in five sites)
Number of subjects: 79
Study 376132 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy
Number of subjects: 79
Study 376132 — intervention group
Group type: COMPARATOR
Intervention: Combination chemotherapy with MER
Number of subjects: 79
Study 31887853 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg preoperatively
Number of subjects: 51
Study 31887853 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block postoperatively
Number of subjects: 51
Study 31887853 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study 30811709 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive therapy
Number of subjects: 74
Study 30811709 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy
Number of subjects: 74
Study 26094723 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg t.d.s for 12 weeks, along with prednisolone 40 mg o.d. tapered over 12 weeks.
Number of subjects: 20
Study 26094723 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofazimine 100 mg t.d.s for 12 weeks, along with prednisolone 40 mg o.d. tapered over 12 weeks.
Number of subjects: 20
Study 26094723 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified, but receiving prednisolone).
Number of subjects: 20
Study 24089075 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 0
Study 24089075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22959555 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-h infusion of 0.5 g doripenem every 8 hours for seven doses
Number of subjects: 0
Study 22959555 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-h infusion of 0.5 g doripenem every 8 hours for seven doses
Number of subjects: 0
Study 19079316 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR-based preemptive therapy (group A)
Number of subjects: 409
Study 19079316 — intervention group
Group type: COMPARATOR
Intervention: Empirical antifungal therapy with liposomal amphotericin B (group B)
Number of subjects: 409
Study 17321989 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 218
Study 17321989 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 218
Study 17321989 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 218
Study 15073702 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming garment (thermoregulation system)
Number of subjects: 18
Study 15073702 — intervention group
Group type: COMPARATOR
Intervention: Routine thermal care (control)
Number of subjects: 18
Study 11192306 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration (MUF)
Number of subjects: 18
Study 11192306 — intervention group
Group type: COMPARATOR
Intervention: Control (no MUF)
Number of subjects: 18
Study 9682315 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire
Number of subjects: 0
Study 9682315 — intervention group
Group type: EXPERIMENTAL
Intervention: Opto-electric device
Number of subjects: 0
Study 7745232 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular glucagon (GLU, 1 mg)
Number of subjects: 48
Study 7745232 — intervention group
Group type: COMPARATOR
Intervention: Intravenous glucagon (GLU, 1 mg)
Number of subjects: 48
Study 7745232 — intervention group
Group type: COMPARATOR
Intervention: Intravenous glucagon (GLU, 1 mg) with GHRH (1 microgram/kg)
Number of subjects: 48
Study 7745232 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular glucagon (GLU, 1 mg) with GHRH (1 microgram/kg)
Number of subjects: 48
Study 2498967 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 0
Study 2498967 — intervention group
Group type: COMPARATOR
Intervention: Ritanserin
Number of subjects: 0
Study 31119419 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 30
Study 31119419 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine
Number of subjects: 30
Study 31119419 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 28241785 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic pain assessment intervention with observational scales and training sessions.
Number of subjects: 164
Study 28241785 — intervention group
Group type: COMPARATOR
Intervention: Comparison group with no systematic pain assessment, continued usual pain management.
Number of subjects: 164
Study 28241785 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing pain documentation practices.
Number of subjects: 164
Study 28241785 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse group interviews regarding pain assessments.
Number of subjects: 164
Study 25984808 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Promotion Program (HPP) for children with DCD (n = 22)
Number of subjects: 41
Study 25984808 — intervention group
Group type: COMPARATOR
Intervention: Health Promotion Program (HPP) for children without DCD (n = 19)
Number of subjects: 41
Study 23994854 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluctophoresis
Number of subjects: 160
Study 23994854 — intervention group
Group type: EXPERIMENTAL
Intervention: Mildronat fluctophoresis
Number of subjects: 160
Study 23994854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivaline fluctophoresis
Number of subjects: 160
Study 23994854 — intervention group
Group type: EXPERIMENTAL
Intervention: Acovegine fluctophoresis
Number of subjects: 160
Study 21189374 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen (PSA) screening
Number of subjects: 0
Study 21189374 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PSA screening)
Number of subjects: 0
Study 19339147 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselor with better motivational interviewing (MI) skills
Number of subjects: 95
Study 19339147 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselor with poorer MI skills
Number of subjects: 95
Study 19339147 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance of MI‐inconsistent skills
Number of subjects: 95
Study 17416207 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrally measured ejection fraction
Number of subjects: 7016
Study 17416207 — intervention group
Group type: COMPARATOR
Intervention: Investigator-measured ejection fraction
Number of subjects: 7016
Study 15361500 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP571 (10 mg/kg)
Number of subjects: 396
Study 15361500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study 15361500 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP571 (10 mg/kg) in patients with baseline CRP >=10 mg/l
Number of subjects: 396
Study 15361500 — intervention group
Group type: COMPARATOR
Intervention: Placebo in patients with baseline CRP >=10 mg/l
Number of subjects: 396
Study 11603594 — intervention group
Group type: EXPERIMENTAL
Intervention: Silzone valves
Number of subjects: 807
Study 11603594 — intervention group
Group type: COMPARATOR
Intervention: Conventional valves
Number of subjects: 807
Study 11603594 — intervention group
Group type: EXPERIMENTAL
Intervention: NA centers
Number of subjects: 807
Study 11603594 — intervention group
Group type: COMPARATOR
Intervention: EU centers
Number of subjects: 807
Study 11603594 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 807
Study 9844753 — intervention group
Group type: EXPERIMENTAL
Intervention: melatonin 5‐mg fast‐release (FR) formulation
Number of subjects: 320
Study 9844753 — intervention group
Group type: EXPERIMENTAL
Intervention: melatonin 0.5‐mg fast‐release (FR) formulation
Number of subjects: 320
Study 9844753 — intervention group
Group type: EXPERIMENTAL
Intervention: melatonin 2‐mg controlled‐release (CR) formulation
Number of subjects: 320
Study 9844753 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 320
Study 7986000 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (200 mg, every 12 h, orally for 5 days)
Number of subjects: 47
Study 7986000 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone (3 g, once daily, intravenously for 3 days)
Number of subjects: 47
Study 7986000 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 47
Study 7986000 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 47
Study 2658458 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 200 mg x 3
Number of subjects: 131
Study 2658458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 31687079 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum folate concentrations in women
Number of subjects: 5581
Study 31687079 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary folate concentrations in women
Number of subjects: 5581
Study 31687079 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum vitamin B12 concentrations in women
Number of subjects: 5581
Study 31687079 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary vitamin B12 concentrations in women
Number of subjects: 5581
Study 31687079 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 5581
Study 27572548 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg
Number of subjects: 40
Study 27572548 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 40
Study 25457793 — intervention group
Group type: EXPERIMENTAL
Intervention: ENCOURAGE intervention (group-based lifestyle program)
Number of subjects: 0
Study 23260750 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acid emulsion (0.2 g/kg) over 6 h for 3 consecutive days
Number of subjects: 49
Study 23260750 — intervention group
Group type: COMPARATOR
Intervention: Control (no n-3 fatty acid emulsion)
Number of subjects: 49
Study 21785346 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative fluid protocol
Number of subjects: 1000
Study 21785346 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal fluid protocol
Number of subjects: 1000
Study 21785346 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients meeting acute kidney injury criteria after adjustment for fluid balance
Number of subjects: 1000
Study 21785346 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with acute kidney injury before but not after adjustment for fluid balance
Number of subjects: 1000
Study 21785346 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients meeting acute kidney injury criteria after but not before adjustment for fluid balance
Number of subjects: 1000
Study 18496338 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (percutaneous radiofrequency neurotomy)
Number of subjects: 40
Study 18496338 — intervention group
Group type: COMPARATOR
Intervention: Control (sham treatment)
Number of subjects: 40
Study 16890833 — intervention group
Group type: EXPERIMENTAL
Intervention: tipranavir-ritonavir
Number of subjects: 746
Study 16890833 — intervention group
Group type: COMPARATOR
Intervention: CPI-ritonavir
Number of subjects: 746
Study 15517441 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (3 MU/cm²)
Number of subjects: 20
Study 15517441 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (2 MU/cm²)
Number of subjects: 20
Study 11766159 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory tones (500 Hz, range 54‐90 dB, 5‐sec duration)
Number of subjects: 11
Study 11766159 — intervention group
Group type: COMPARATOR
Intervention: Sham tone (recording with no tone)
Number of subjects: 11
Study 9164808 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-mineral formula (510 mg of calcium per liter and 390 mg of phosphorus per liter)
Number of subjects: 101
Study 9164808 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-mineral formula
Number of subjects: 101
Study 9164808 — intervention group
Group type: COMPARATOR
Intervention: Human milk
Number of subjects: 101
Study 9164808 — intervention group
Group type: COMPARATOR
Intervention: Low-mineral formula
Number of subjects: 101